Protein aggregation and neurodegeneration.
作者信息
Mayo Katie J, Cyr Douglas M
出版信息
Methods. 2011 Mar;53(3):185-6. doi: 10.1016/j.ymeth.2011.02.009.
Abstract
摘要
相似文献
1
Protein aggregation and neurodegeneration.蛋白质聚集与神经退行性变。
Methods. 2011 Mar;53(3):185-6. doi: 10.1016/j.ymeth.2011.02.009.
2
Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?蛋白质错误折叠、淀粉样蛋白形成与神经退行性变：分子伴侣的关键作用？
Neuron. 2002 Jul 3;35(1):9-12. doi: 10.1016/s0896-6273(02)00761-4.
3
Protein misfolding and neurodegeneration.蛋白质错误折叠与神经退行性变。
Arch Neurol. 2008 Feb;65(2):184-9. doi: 10.1001/archneurol.2007.56.
4
Bridging the gap: from protein misfolding to protein misfolding diseases.弥合差距：从蛋白质错误折叠到蛋白质错误折叠疾病。
FEBS Lett. 2009 Aug 20;583(16):2581-6. doi: 10.1016/j.febslet.2009.06.030. Epub 2009 Jun 21.
5
Protein folding: The dark side of proteins.蛋白质折叠：蛋白质的阴暗面。
Nature. 2010 Apr 8;464(7290):828-9. doi: 10.1038/464828a.
6
Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases?预防蛋白质聚集体能否兑现其作为神经退行性疾病预防手段的承诺？
Brain Pathol. 2003 Oct;13(4):630-8. doi: 10.1111/j.1750-3639.2003.tb00491.x.
7
Disentangling a Bad Reputation: Changing Perceptions of Amyloids.摆脱不良声誉：改变对淀粉样蛋白的认知。
Trends Cell Biol. 2017 Jul;27(7):465-467. doi: 10.1016/j.tcb.2017.03.001. Epub 2017 Mar 27.
8
Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases.与年龄相关的神经退行性疾病中蛋白质聚集机制的结构研究。
Mech Ageing Dev. 2016 Jun;156:1-13. doi: 10.1016/j.mad.2016.03.001. Epub 2016 Mar 19.
9
Generic cell dysfunction in neurodegenerative disorders: role of surfaces in early protein misfolding, aggregation, and aggregate cytotoxicity.神经退行性疾病中的一般细胞功能障碍：表面在早期蛋白质错误折叠、聚集及聚集体细胞毒性中的作用
Neuroscientist. 2007 Oct;13(5):519-31. doi: 10.1177/1073858407303428.
10
Amyloid in neurodegenerative diseases: friend or foe?神经退行性疾病中的淀粉样蛋白：是敌是友？
Semin Cell Dev Biol. 2011 Jul;22(5):476-81. doi: 10.1016/j.semcdb.2011.03.011. Epub 2011 Mar 31.
引用本文的文献
1
Food-Derived Antioxidant Polysaccharides and Their Pharmacological Potential in Neurodegenerative Diseases.食物来源的抗氧化多糖及其在神经退行性疾病中的药理学潜力。
Nutrients. 2017 Jul 19;9(7):778. doi: 10.3390/nu9070778.
本文引用的文献
1
Amyloid deposits: protection against toxic protein species?淀粉样沉积物：对有毒蛋白质种类的保护作用？
Cell Cycle. 2009 Jun 1;8(11):1668-74. doi: 10.4161/cc.8.11.8503. Epub 2009 Jun 20.
2
Modulation of prion-dependent polyglutamine aggregation and toxicity by chaperone proteins in the yeast model.酵母模型中伴侣蛋白对朊病毒依赖性多聚谷氨酰胺聚集及毒性的调控
J Biol Chem. 2005 Jun 17;280(24):22809-18. doi: 10.1074/jbc.M500390200. Epub 2005 Apr 11.
3
A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease.酵母中的基因组筛选表明犬尿氨酸3-单加氧酶是亨廷顿病的治疗靶点。
Nat Genet. 2005 May;37(5):526-31. doi: 10.1038/ng1542. Epub 2005 Apr 3.
4
Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation.全基因组RNA干扰筛选鉴定出以前未描述的聚谷氨酰胺聚集调节因子。
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6403-8. doi: 10.1073/pnas.0307697101. Epub 2004 Apr 14.
5
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein.可增强突变型亨廷顿蛋白片段或α-突触核蛋白毒性的酵母基因。
Science. 2003 Dec 5;302(5651):1769-72. doi: 10.1126/science.1090389.
6
Polyglutamine protein aggregates are dynamic.多聚谷氨酰胺蛋白聚集体是动态的。
Nat Cell Biol. 2002 Oct;4(10):826-31. doi: 10.1038/ncb863.
7
Identification of genes that modify ataxin-1-induced neurodegeneration.鉴定修饰ataxin-1诱导的神经退行性变的基因。
Nature. 2000 Nov 2;408(6808):101-6. doi: 10.1038/35040584.
8
Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils.热休克蛋白70（Hsp70）和热休克蛋白40（hsp40）分子伴侣可抑制聚谷氨酰胺蛋白自组装成淀粉样纤维。
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7841-6. doi: 10.1073/pnas.140202897.
9
Conformational disease.构象病
Lancet. 1997 Jul 12;350(9071):134-8. doi: 10.1016/S0140-6736(97)02073-4.
Zotero 插件